Silencing synapses

References

• Caleo M, Restani L, Vannini E, Siskova Z, Al-Malki H, Morgan R, et al. The role of activity in synaptic degeneration in a protein misfolding disease, prion disease. PLoS One 2012; 7:e41182; http://dx.doi.org/10.1371/journal.pone.0041182; PMID: 22815961
   PubMedGoogle Scholar
• Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572 - 80; http://dx.doi.org/10.1002/ana.410300410; PMID: 1789684
   PubMed Web of Science ®Google Scholar
• Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 2000; 26:41 - 54; http://dx.doi.org/10.1046/j.1365-2990.2000.00216.x; PMID: 10736066
   PubMed Web of Science ®Google Scholar
• Sisková Z, Page A, O’Connor V, Perry VH. Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. Am J Pathol 2009; 175:1610 - 21; PMID: 19779137
   PubMed Web of Science ®Google Scholar
• Gray BC, Siskova Z, Perry VH, O’Connor V. Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology. Neurobiol Dis 2009; 35:63 - 74; http://dx.doi.org/10.1016/j.nbd.2009.04.001; PMID: 19362593
   PubMed Web of Science ®Google Scholar
• Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 2006; 9:408 - 19; http://dx.doi.org/10.1038/nn1653; PMID: 16474388
   PubMed Web of Science ®Google Scholar
• Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 2003; 17:2147 - 55; http://dx.doi.org/10.1046/j.1460-9568.2003.02662.x; PMID: 12786981
   PubMed Web of Science ®Google Scholar
• Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005; 48:913 - 22; http://dx.doi.org/10.1016/j.neuron.2005.10.028; PMID: 16364896
   PubMed Web of Science ®Google Scholar
• Koch P, Breuer P, Peitz M, Jungverdorben J, Kesavan J, Poppe D, et al. Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature 2011; 480:543 - 6; PMID: 22113611
   PubMed Web of Science ®Google Scholar
• Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 2010; 13:190 - 6; http://dx.doi.org/10.1038/nn.2476; PMID: 20037574
   PubMed Web of Science ®Google Scholar
• Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25:7709 - 17; http://dx.doi.org/10.1523/JNEUROSCI.2177-05.2005; PMID: 16120771
   PubMed Web of Science ®Google Scholar
• Berardi N, Braschi C, Capsoni S, Cattaneo A, Maffei L. Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration. J Alzheimers Dis 2007; 11:359 - 70; PMID: 17851186
   PubMed Web of Science ®Google Scholar
• Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 2006; 7:697 - 709; http://dx.doi.org/10.1038/nrn1970; PMID: 16924259
   PubMed Web of Science ®Google Scholar
• Montecucco C, Molgó J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol 2005; 5:274 - 9; http://dx.doi.org/10.1016/j.coph.2004.12.006; PMID: 15907915
   PubMed Web of Science ®Google Scholar
• Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000; 80:717 - 66; PMID: 10747206
   PubMed Web of Science ®Google Scholar
• Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 2008; 28:3689 - 96; http://dx.doi.org/10.1523/JNEUROSCI.0375-08.2008; PMID: 18385327
   PubMed Web of Science ®Google Scholar
• Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S, et al. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 2004; 41:599 - 610; http://dx.doi.org/10.1016/S0896-6273(04)00077-7; PMID: 14980208
   PubMed Web of Science ®Google Scholar
• Capogna M, McKinney RA, O’Connor V, Gähwiler BH, Thompson SM. Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J Neurosci 1997; 17:7190 - 202; PMID: 9295365
   PubMed Web of Science ®Google Scholar
• Caleo M, Antonucci F, Restani L, Mazzocchio R. A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?. J Neurochem 2009; 109:15 - 24; http://dx.doi.org/10.1111/j.1471-4159.2009.05887.x; PMID: 19154335
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Falsig J. Prion propagation, toxicity and degradation. Nat Neurosci 2012; 15:936 - 9; http://dx.doi.org/10.1038/nn.3120; PMID: 22735515
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Resolving controversies on the path to Alzheimer’s therapeutics. Nat Med 2011; 17:1060 - 5; http://dx.doi.org/10.1038/nm.2460; PMID: 21900936
   PubMed Web of Science ®Google Scholar
• Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, et al. Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature 2012; 485:507 - 11; PMID: 22622579
   PubMed Web of Science ®Google Scholar
• Sharma M, Burré J, Bronk P, Zhang Y, Xu W, Südhof TC. CSPα knockout causes neurodegeneration by impairing SNAP-25 function. EMBO J 2012; 31:829 - 41; http://dx.doi.org/10.1038/emboj.2011.467; PMID: 22187053
   PubMed Web of Science ®Google Scholar
• Sharma M, Burré J, Südhof TC. Proteasome inhibition alleviates SNARE-dependent neurodegeneration. Sci Transl Med 2012; 4:ra113; http://dx.doi.org/10.1126/scitranslmed.3004028; PMID: 22896677
   PubMed Web of Science ®Google Scholar
• Fernández-Chacón R, Wölfel M, Nishimune H, Tabares L, Schmitz F, Castellano-Muñoz M, et al. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron 2004; 42:237 - 51; http://dx.doi.org/10.1016/S0896-6273(04)00190-4; PMID: 15091340
   PubMed Web of Science ®Google Scholar
• García-Junco-Clemente P, Cantero G, Gómez-Sánchez L, Linares-Clemente P, Martínez-López JA, Luján R, et al. Cysteine string protein-alpha prevents activity-dependent degeneration in GABAergic synapses. J Neurosci 2010; 30:7377 - 91; http://dx.doi.org/10.1523/JNEUROSCI.0924-10.2010; PMID: 20505105
   PubMed Web of Science ®Google Scholar
• Bajohrs M, Rickman C, Binz T, Davletov B. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. EMBO Rep 2004; 5:1090 - 5; http://dx.doi.org/10.1038/sj.embor.7400278; PMID: 15486565
   PubMed Web of Science ®Google Scholar
• Asuni AA, Cunningham C, Vigneswaran P, Perry VH, O’Connor V. Unaltered SNARE complex formation in an in vivo model of prion disease. Brain Res 2008; 1233:1 - 7; http://dx.doi.org/10.1016/j.brainres.2008.07.083; PMID: 18706894
   PubMed Web of Science ®Google Scholar
• Chandra S, Gallardo G, Fernández-Chacón R, Schlüter OM, Südhof TC. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005; 123:383 - 96; http://dx.doi.org/10.1016/j.cell.2005.09.028; PMID: 16269331
   PubMed Web of Science ®Google Scholar
• Burré J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Südhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010; 329:1663 - 7; http://dx.doi.org/10.1126/science.1195227; PMID: 20798282
   PubMed Web of Science ®Google Scholar
• Asuni AA, Hilton K, Siskova Z, Lunnon K, Reynolds R, Perry VH, et al. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease. Neuroscience 2010; 165:662 - 74; http://dx.doi.org/10.1016/j.neuroscience.2009.10.047; PMID: 19879926
   PubMed Web of Science ®Google Scholar